Clinical Trials Logo

Hookworm Infection clinical trials

View clinical trials related to Hookworm Infection.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00473967 Terminated - Hookworm Infection Clinical Trials

Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults

Start date: May 2007
Phase: Phase 1
Study type: Interventional

Na-ASP-2 is a protein expressed during the larval stage of the N. americanus hookworm life cycle. Vaccination with recombinant ASP-2 has protected dogs and hamsters from infection in challenge studies. In a clinical study in hookworm-uninfected adults in the USA, Na-ASP-2 Hookworm Vaccine was safe and immunogenic. This study will evaluate its safety and immunogenicity in individuals living in an area of endemic hookworm infection.